Pei Yang

Dr. Pei Yang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
XWXianhao Wu
Xianhao Wu
RTRui Tao
Rui Tao
TZTianyao Zhang
Tianyao Zhang
XLXing Liu
Xing Liu
JWJiangfei Wang
Jiangfei Wang
PYPei Yang
Pei Yang

1 July 2020 in Clinical Immunology
Verified
Journal Article
Closed access
XSXia Shan
Xia Shan
CZChuanbao Zhang
Chuanbao Zhang
ZWZheng Wang
Zheng Wang
KWKuanyu Wang
Kuanyu Wang
JWJiangfei Wang
Jiangfei Wang
PYPei Yang
Pei Yang

16 March 2023 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
ZSZhiyan Sun
Zhiyan Sun
XWXianhao Wu
Xianhao Wu
RTRui Tao
Rui Tao
TZTianyao Zhang
Tianyao Zhang
XLXing Liu
Xing Liu
PYPei Yang
Pei Yang

12 February 2021 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
PYPei Yang
Pei Yang
KWKuanyu Wang
Kuanyu Wang
CZChuanbao Zhang
Chuanbao Zhang
ZWZhiliang Wang
Zhiliang Wang
QLQi Liu
Qi Liu
XSXia Shan
Xia Shan

26 April 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
XWXianhao Wu
Xianhao Wu
RTRui Tao
Rui Tao
ZSZhiyan Sun
Zhiyan Sun
TZTianyao Zhang
Tianyao Zhang
XLXingyue Li
Xingyue Li
PYPei Yang
Pei Yang

27 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZSZhiyan Sun
Zhiyan Sun
MDMinghui Du
Minghui Du
XWXianhao Wu
Xianhao Wu
RTRui Tao
Rui Tao
PSPeiyuan Sun
Peiyuan Sun
PYPei Yang
Pei Yang
Glioblastoma (GBM) is a highly aggressive brain tumor with poor outcomes and limited treatment options. The telomerase reverse transcriptase (TERT) promoter mutation, one of the key biomarkers in GBM, is linked to tumor progression and prognosis. This study employed terahertz time-domain spectroscopy (THz-TDS) to analyze frozen GBM tissue sections, extracting six spectral features: absorption coefficient, dielectric loss factor, dielectric constant, extinction coefficient, refractive index, and dielectric loss tangent. LASSO regression was employed for feature selection, and then principal component analysis (PCA) was applied to minimize inter-feature correlations. A Random Forest classifier built on these features successfully predicted TERT mutation status, achieving an area under the receiver operating characteristic curve (AUC) of 0.908 in the validation set. Our findings demonstrate that THz spectroscopy, coupled with machine learning, can identify molecular differences associated with TERT mutations, supporting its potential as a rapid, intraoperative diagnostic tool for personalized GBM treatment. This approach could enhance surgical decision-making and optimize patient outcomes through precise, real-time molecular diagnostics.